Open for Enrollment Soon
This study will open for enrollment soon. Please contact the study team for more information and check back frequently.

PRECEDE (Cesarean C-Section Delivery) - Clinical Trial

What is the Purpose of this Study?

We are doing this study to find out if adding azithromycin to the routine single antibiotic preventative therapy can lower the risk of developing infections after a cesarean delivery.

What is the Condition Being Studied?

Cesarean [C-Section] Delivery

Who Can Participate in the Study?

Adults ages 18+ who are pregnant and will be having a scheduled cesarean delivery at Duke University Hospital.

For more information, contact the study team at jennifer.ferrara@duke.edu.

Age Group
Adults, Children

What is Involved?

If you choose to join this study, you will get a random assignment (like a coin flip) to receive either azithromycin or placebo (normal saline) through your existing intravenous (IV) line that is placed before you have your baby. Study participation starts when you come to the hospital to deliver your baby and will end approximately 6 weeks after delivery.

Study Details

Full Title
Azithromycin Prophylaxis for Prelabor Cesarean Delivery Trial
Principal Investigator
Maternal-Fetal Medicine Specialist
Protocol Number
IRB: PRO00115734
NCT: NCT06605118
Phase
Phase III
ClinicalTrials.gov
Enrollment Status
Open for Enrollment Soon